SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (369)6/22/1999 1:45:00 PM
From: Biomaven  Respond to of 626
 
David,

The transcript more or less confirms earlier estimates that Novartis is spending $100m on the Zomaril (Iloperidone) Phase III's. I'm not sure I ever pointed this thread to a kind of off-the-wall valuation estimate for Zomaril (and hence TTP) I did a few months back based on this fact:

Message 8082836

Transcript says they are going to file a NDA for Spheramine in the next month or so. Don't really have a clue as to whether this is value adding or subtracting <g>.

Peter